| Income Statement |
| Total Revenue | 3.83M |
|
| Revenues (USD) | 2.74M |
| Cost of Revenue | 1.59M |
| Gross Profit | 2.25M |
| Operating Expenses | 8.38M |
| Research and Development Expense | 1.29M |
| Selling, General and Administrative Expense | 7.09M |
| Operating Income | -6.13M |
| Income Tax Expense | 158.00K |
| Net Income | -6.08M |
| Net Income Common Stock | -6.08M |
| Net Income Common Stock (USD) | -4.34M |
| Consolidated Income | -6.08M |
| Earnings per Basic Share | -0.13 |
| Earnings per Basic Share (USD) | -0.09 |
| Earnings per Diluted Share | -0.13 |
| Earning Before Interest & Taxes (EBIT) | -5.93M |
| Earning Before Interest & Taxes (USD) | -4.23M |
| Weighted Average Shares | 46.81M |
| Weighted Average Shares Diluted | 46.81M |
| Balance Sheet |
| Cash and Equivalents | 7.75M |
| Cash and Equivalents (USD) | 5.53M |
| Trade and Non-Trade Receivables | 851.00K |
| Current Assets | 12.21M |
| Property, Plant & Equipment Net | 4.00M |
| Total Assets | 17.32M |
| Debt Current | 483.00K |
| Total Debt | 3.48M |
| Current Liabilities | 6.64M |
| Debt Non-Current | 3.00M |
| Total Liabilities | 10.41M |
| Accumulated Retained Earnings (Deficit) | -148.83M |
| Accumulated Other Comprehensive Income | 3.10M |
| Shareholders Equity | 6.91M |
| Shareholders Equity (USD) | 4.93M |
| Assets Non-Current | 5.11M |
| Total Debt (USD) | 2.49M |
| Deferred Revenue | 529.00K |
| Inventory | 611.00K |
| Liabilities Non-Current | 3.77M |
| Trade and Non-Trade Payables | 5.44M |
| Tax Assets | 1.31M |
| Tax Liabilities | 957.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 266.00K |
| Net Cash Flow from Financing | 346.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.77M |
| Capital Expenditure | -78.00K |
| Issuance (Purchase) of Equity Shares | 525.00K |
| Issuance (Repayment) of Debt Securities | -179.00K |
| Net Cash Flow from Investing | -78.00K |
| Net Cash Flow from Operations | -4.04M |
| Share Based Compensation | 740.00K |